PT95494B - Processo para a producao de dna recombinante compreendendo sequencias derivadas de virus de rna, e manipulacoes geneticas que o utilizam - Google Patents
Processo para a producao de dna recombinante compreendendo sequencias derivadas de virus de rna, e manipulacoes geneticas que o utilizam Download PDFInfo
- Publication number
- PT95494B PT95494B PT95494A PT9549490A PT95494B PT 95494 B PT95494 B PT 95494B PT 95494 A PT95494 A PT 95494A PT 9549490 A PT9549490 A PT 9549490A PT 95494 B PT95494 B PT 95494B
- Authority
- PT
- Portugal
- Prior art keywords
- rna
- viral
- sequence
- virus
- derived
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 47
- 108020004511 Recombinant DNA Proteins 0.000 title claims abstract description 36
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 15
- 241000700605 Viruses Species 0.000 title claims description 78
- 230000002068 genetic effect Effects 0.000 title claims description 14
- 230000008569 process Effects 0.000 title claims description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims abstract description 154
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 135
- 241001493065 dsRNA viruses Species 0.000 claims abstract description 74
- 230000010076 replication Effects 0.000 claims abstract description 70
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 69
- 239000002773 nucleotide Substances 0.000 claims abstract description 44
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 44
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims abstract description 41
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 claims abstract description 40
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims abstract description 37
- 210000004027 cell Anatomy 0.000 claims abstract description 36
- 108020000999 Viral RNA Proteins 0.000 claims abstract description 35
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 32
- 230000001939 inductive effect Effects 0.000 claims abstract description 20
- 108090000565 Capsid Proteins Proteins 0.000 claims abstract description 19
- 230000001419 dependent effect Effects 0.000 claims abstract description 19
- 238000010353 genetic engineering Methods 0.000 claims abstract description 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 16
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 14
- 210000003527 eukaryotic cell Anatomy 0.000 claims abstract description 5
- 210000001236 prokaryotic cell Anatomy 0.000 claims abstract description 4
- 241000196324 Embryophyta Species 0.000 claims description 76
- 208000015181 infectious disease Diseases 0.000 claims description 68
- 230000003612 virological effect Effects 0.000 claims description 47
- 108020004999 messenger RNA Proteins 0.000 claims description 17
- 238000013519 translation Methods 0.000 claims description 16
- 108090000994 Catalytic RNA Proteins 0.000 claims description 15
- 102000053642 Catalytic RNA Human genes 0.000 claims description 15
- 108020004705 Codon Proteins 0.000 claims description 15
- 238000010276 construction Methods 0.000 claims description 15
- 108091092562 ribozyme Proteins 0.000 claims description 15
- 238000013518 transcription Methods 0.000 claims description 14
- 230000035897 transcription Effects 0.000 claims description 14
- 108020004414 DNA Proteins 0.000 claims description 13
- 102100023321 Ceruloplasmin Human genes 0.000 claims description 10
- 238000003786 synthesis reaction Methods 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000002955 isolation Methods 0.000 claims description 5
- 238000010348 incorporation Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 241000233866 Fungi Species 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 108010067390 Viral Proteins Proteins 0.000 claims description 2
- 229920000742 Cotton Polymers 0.000 claims 2
- 239000000470 constituent Substances 0.000 claims 2
- 230000006269 (delayed) early viral mRNA transcription Effects 0.000 claims 1
- 101000798396 Bacillus licheniformis Phenylalanine racemase [ATP hydrolyzing] Proteins 0.000 claims 1
- 101001022703 Bacillus subtilis ATP-dependent asparagine adenylase 1 Proteins 0.000 claims 1
- 230000006820 DNA synthesis Effects 0.000 claims 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 1
- 108020004566 Transfer RNA Proteins 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 239000013612 plasmid Substances 0.000 description 65
- 235000018102 proteins Nutrition 0.000 description 63
- 241000709655 unidentified tobacco necrosis virus Species 0.000 description 55
- 239000012634 fragment Substances 0.000 description 40
- 239000011248 coating agent Substances 0.000 description 34
- 238000000576 coating method Methods 0.000 description 34
- 238000012217 deletion Methods 0.000 description 23
- 230000037430 deletion Effects 0.000 description 23
- 238000003780 insertion Methods 0.000 description 21
- 230000037431 insertion Effects 0.000 description 21
- 101710132601 Capsid protein Proteins 0.000 description 18
- 101710094648 Coat protein Proteins 0.000 description 18
- 101710125418 Major capsid protein Proteins 0.000 description 18
- 101710141454 Nucleoprotein Proteins 0.000 description 18
- 101710083689 Probable capsid protein Proteins 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 18
- 244000061176 Nicotiana tabacum Species 0.000 description 16
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 16
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 12
- 239000002054 inoculum Substances 0.000 description 12
- 230000009466 transformation Effects 0.000 description 12
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 11
- 239000002245 particle Substances 0.000 description 11
- 230000014616 translation Effects 0.000 description 11
- 150000001413 amino acids Chemical class 0.000 description 10
- 230000000692 anti-sense effect Effects 0.000 description 10
- 229930027917 kanamycin Natural products 0.000 description 10
- 229960000318 kanamycin Drugs 0.000 description 10
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 10
- 229930182823 kanamycin A Natural products 0.000 description 10
- 238000012546 transfer Methods 0.000 description 10
- 230000035772 mutation Effects 0.000 description 9
- 241001107116 Castanospermum australe Species 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 235000021279 black bean Nutrition 0.000 description 8
- 230000003902 lesion Effects 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000010367 cloning Methods 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 241000219977 Vigna Species 0.000 description 6
- 235000010726 Vigna sinensis Nutrition 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000001262 western blot Methods 0.000 description 6
- 208000036142 Viral infection Diseases 0.000 description 5
- 238000005520 cutting process Methods 0.000 description 5
- 230000002950 deficient Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 230000004927 fusion Effects 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000002458 infectious effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000009385 viral infection Effects 0.000 description 5
- 101100494773 Caenorhabditis elegans ctl-2 gene Proteins 0.000 description 4
- 102000014914 Carrier Proteins Human genes 0.000 description 4
- 108010078791 Carrier Proteins Proteins 0.000 description 4
- 208000003322 Coinfection Diseases 0.000 description 4
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 4
- IMXSCCDUAFEIOE-RITPCOANSA-N D-octopine Chemical compound [O-]C(=O)[C@@H](C)[NH2+][C@H](C([O-])=O)CCCNC(N)=[NH2+] IMXSCCDUAFEIOE-RITPCOANSA-N 0.000 description 4
- 101100112369 Fasciola hepatica Cat-1 gene Proteins 0.000 description 4
- 108010060309 Glucuronidase Proteins 0.000 description 4
- 101100005271 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cat-1 gene Proteins 0.000 description 4
- 241001515849 Satellite Viruses Species 0.000 description 4
- 241000723873 Tobacco mosaic virus Species 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 229960005091 chloramphenicol Drugs 0.000 description 4
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000006870 ms-medium Substances 0.000 description 4
- 230000017074 necrotic cell death Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 101800004538 Bradykinin Proteins 0.000 description 3
- 102400000967 Bradykinin Human genes 0.000 description 3
- 101100465058 Caenorhabditis elegans prk-2 gene Proteins 0.000 description 3
- 101100468275 Caenorhabditis elegans rep-1 gene Proteins 0.000 description 3
- 229930182566 Gentamicin Natural products 0.000 description 3
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 3
- 102000053187 Glucuronidase Human genes 0.000 description 3
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- 241000219833 Phaseolus Species 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 108091081024 Start codon Proteins 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 229960002518 gentamicin Drugs 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 230000001018 virulence Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 108020005544 Antisense RNA Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000714206 Carnation mottle virus Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 101150087882 GUS1 gene Proteins 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 241000272534 Struthio camelus Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 101150055766 cat gene Proteins 0.000 description 2
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 2
- 239000004062 cytokinin Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- GGKNTGJPGZQNID-UHFFFAOYSA-N (1-$l^{1}-oxidanyl-2,2,6,6-tetramethylpiperidin-4-yl)-trimethylazanium Chemical compound CC1(C)CC([N+](C)(C)C)CC(C)(C)N1[O] GGKNTGJPGZQNID-UHFFFAOYSA-N 0.000 description 1
- 102100030492 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 Human genes 0.000 description 1
- JTNGEYANGCBZLK-UHFFFAOYSA-N 1h-indol-3-yl dihydrogen phosphate Chemical compound C1=CC=C2C(OP(O)(=O)O)=CNC2=C1 JTNGEYANGCBZLK-UHFFFAOYSA-N 0.000 description 1
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
- 102100039601 ARF GTPase-activating protein GIT1 Human genes 0.000 description 1
- 101710194905 ARF GTPase-activating protein GIT1 Proteins 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000319138 Amauris niavius Species 0.000 description 1
- 241000712892 Arenaviridae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 101150116295 CAT2 gene Proteins 0.000 description 1
- 101100326920 Caenorhabditis elegans ctl-1 gene Proteins 0.000 description 1
- 101100326684 Caenorhabditis elegans tra-3 gene Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108091028075 Circular RNA Proteins 0.000 description 1
- LMKYZBGVKHTLTN-NKWVEPMBSA-N D-nopaline Chemical compound NC(=N)NCCC[C@@H](C(O)=O)N[C@@H](C(O)=O)CCC(O)=O LMKYZBGVKHTLTN-NKWVEPMBSA-N 0.000 description 1
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001517310 Eria Species 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 101710081758 High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 102220512493 Homeobox protein Nkx-2.5_N19S_mutation Human genes 0.000 description 1
- 101000829958 Homo sapiens N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Proteins 0.000 description 1
- 101000590492 Homo sapiens Nuclear fragile X mental retardation-interacting protein 1 Proteins 0.000 description 1
- 101100408465 Homo sapiens PLCE1 gene Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 102100023315 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Human genes 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 102000003797 Neuropeptides Human genes 0.000 description 1
- 101100126846 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) katG gene Proteins 0.000 description 1
- 101100215778 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ptr-1 gene Proteins 0.000 description 1
- 101100445488 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ptr-2 gene Proteins 0.000 description 1
- 108091060545 Nonsense suppressor Proteins 0.000 description 1
- 102100032428 Nuclear fragile X mental retardation-interacting protein 1 Human genes 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 241000842783 Orna Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101710091688 Patatin Proteins 0.000 description 1
- 241000150350 Peribunyaviridae Species 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 101710150451 Protein Bel-1 Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 241000712907 Retroviridae Species 0.000 description 1
- 108020005543 Satellite RNA Proteins 0.000 description 1
- 102100035897 Secretogranin-3 Human genes 0.000 description 1
- 101710192382 Secretogranin-3 Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000712465 Sonchus yellow net nucleorhabdovirus Species 0.000 description 1
- 108091027544 Subgenomic mRNA Proteins 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 241000724291 Tobacco streak virus Species 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 240000006064 Urena lobata Species 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000014797 chronic intestinal pseudoobstruction Diseases 0.000 description 1
- 229940088530 claforan Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000018999 crinkle Diseases 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000005462 in vivo assay Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000011890 leaf development Effects 0.000 description 1
- 235000020121 low-fat milk Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- KRZWEBVPFGCYMY-UHFFFAOYSA-M methylmercury(1+);hydroxide Chemical compound [OH-].[Hg+]C KRZWEBVPFGCYMY-UHFFFAOYSA-M 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N naphthalene-acid Natural products C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 1
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229930010796 primary metabolite Natural products 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 101150058668 tra2 gene Proteins 0.000 description 1
- 101150113807 traR gene Proteins 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8203—Virus mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/38011—Tombusviridae
- C12N2770/38022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8902452A NL8902452A (nl) | 1989-10-03 | 1989-10-03 | Genetische manipulaties met recombinant dna, dat rna-virus-specifieke sequenties omvat. |
| NL9001711A NL9001711A (nl) | 1989-10-03 | 1990-07-27 | Genetische manipulaties met recombinant dna, dat van rna virus afgeleide sequenties omvat. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT95494A PT95494A (pt) | 1991-09-13 |
| PT95494B true PT95494B (pt) | 1997-11-28 |
Family
ID=26646589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT95494A PT95494B (pt) | 1989-10-03 | 1990-10-03 | Processo para a producao de dna recombinante compreendendo sequencias derivadas de virus de rna, e manipulacoes geneticas que o utilizam |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6197542B1 (https=) |
| EP (1) | EP0425004B1 (https=) |
| JP (1) | JPH03280883A (https=) |
| AT (1) | ATE142700T1 (https=) |
| CA (2) | CA2396794A1 (https=) |
| DE (1) | DE69028479T2 (https=) |
| DK (1) | DK0425004T3 (https=) |
| ES (1) | ES2094744T3 (https=) |
| GR (1) | GR3021950T3 (https=) |
| IE (1) | IE76133B1 (https=) |
| NL (1) | NL9001711A (https=) |
| PT (1) | PT95494B (https=) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7033835B1 (en) | 1988-02-26 | 2006-04-25 | Large Scale Biology Corporation | Production of peptides in plants as viral coat protein fusions |
| US5922602A (en) * | 1988-02-26 | 1999-07-13 | Biosource Technologies, Inc. | Cytoplasmic inhibition of gene expression |
| US5977438A (en) * | 1988-02-26 | 1999-11-02 | Biosource Technologies, Inc. | Production of peptides in plants as viral coat protein fusions |
| US6660500B2 (en) | 1988-02-26 | 2003-12-09 | Large Scale Biology Corporation | Production of peptides in plants as viral coat protein fusions |
| US6054566A (en) | 1988-02-26 | 2000-04-25 | Biosource Technologies, Inc. | Recombinant animal viral nucleic acids |
| JPH07503361A (ja) * | 1991-08-01 | 1995-04-13 | バイオソース テクノロジーズ インコーポレイティド | 組み換え植物ウィルス核酸 |
| ATE276373T1 (de) * | 1991-10-04 | 2004-10-15 | Univ North Carolina State | Pathogenresistente transgene pflanzen |
| CA2130454C (en) * | 1992-02-19 | 2008-04-08 | William G. Dougherty | Production of viral resistant plants via introduction of untranslatable plus sense viral rna |
| EP0641384A4 (en) * | 1992-05-14 | 1995-07-12 | Ribozyme Pharm Inc | INDUCIBLE CYTOTOXIC mRNAs CONTAINING VIRUS-RESISTANT PLANTS. |
| EP0677113B1 (en) * | 1992-12-30 | 2003-03-12 | Biosource Genetics Corporation | Viral amplification of recombinant messenger rna in transgenic plants |
| IL108241A (en) * | 1992-12-30 | 2000-08-13 | Biosource Genetics Corp | Plant expression system comprising a defective tobamovirus replicon integrated into the plant chromosome and a helper virus |
| US6008436A (en) * | 1993-01-21 | 1999-12-28 | North Carolina State University | Nematode-resistant transgenic plants |
| US5650303A (en) * | 1993-02-26 | 1997-07-22 | Calgene, Inc. | Geminivirus-based gene expression system |
| DK0686197T3 (da) * | 1993-02-26 | 2000-09-04 | Calgene Llc | Geminivirusbaseret genekspressionssystem |
| US5981236A (en) * | 1993-02-26 | 1999-11-09 | Calgene Inc | Geminivirus-based gene expression system |
| DE4315109A1 (de) * | 1993-05-06 | 1994-11-10 | Inst Pflanzengenetik & Kultur | Verfahren und Vektorkonstrukt zur Expressionssteigerung von Transgenen |
| GB9311593D0 (en) * | 1993-06-04 | 1993-07-21 | Sandoz Ltd | Improvements in or relating to organic compounds |
| GB9401780D0 (en) * | 1994-01-31 | 1994-03-23 | Nickerson Biocem Ltd | Modified plants |
| AU3409295A (en) * | 1994-08-18 | 1996-03-14 | Ariad Gene Therapeutics, Inc. | Regulatable elimination of gene expression, gene product function and engineered host cells |
| IT1283631B1 (it) * | 1996-05-09 | 1998-04-23 | Metapontum Agrobios Srl | Metodo per la preparazione di piante transgeniche resistenti ad in- fezioni virali e piante cosi' ottenute |
| GB9615349D0 (en) * | 1996-07-22 | 1996-09-04 | Zeneca Ltd | Virus resistance in plants |
| GB9703146D0 (en) * | 1997-02-14 | 1997-04-02 | Innes John Centre Innov Ltd | Methods and means for gene silencing in transgenic plants |
| GB9720148D0 (en) * | 1997-09-22 | 1997-11-26 | Innes John Centre Innov Ltd | Gene silencing materials and methods |
| AU731330B2 (en) * | 1997-10-24 | 2001-03-29 | E.I. Du Pont De Nemours And Company | Binary viral expression system in plants |
| US6077992A (en) * | 1997-10-24 | 2000-06-20 | E. I. Du Pont De Nemours And Company | Binary viral expression system in plants |
| US6632980B1 (en) | 1997-10-24 | 2003-10-14 | E. I. Du Pont De Nemours And Company | Binary viral expression system in plants |
| US6759243B2 (en) | 1998-01-20 | 2004-07-06 | Board Of Trustees Of The University Of Illinois | High affinity TCR proteins and methods |
| HUP0104697A3 (en) * | 1998-09-23 | 2003-12-29 | Du Pont | Binary viral expression system in plants |
| US7220893B1 (en) | 1999-05-19 | 2007-05-22 | Cornell Research Foundation, Inc. | Plasmids and methods for construction of non-redundant, indexed, saturation, gene-disruption plant and animal libraries |
| US7696406B2 (en) * | 2003-07-03 | 2010-04-13 | Board Of Trustees Operating Michigan State University | Expression of a recombinant transgene |
| CN110144338A (zh) * | 2019-05-29 | 2019-08-20 | 通用生物系统（安徽）有限公司 | 一种以rna为模板的rna聚合酶制备方法及该聚合酶的应用 |
| US12234701B2 (en) | 2022-09-12 | 2025-02-25 | Saudi Arabian Oil Company | Tubing hangers and related methods of isolating a tubing |
| US12188328B2 (en) | 2023-05-15 | 2025-01-07 | Saudi Arabian Oil Company | Wellbore back pressure valve with pressure gauge |
| US12442257B2 (en) | 2023-05-23 | 2025-10-14 | Saudi Arabian Oil Company | Completing and working over a wellbore |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2624342B1 (fr) * | 1987-12-14 | 1991-11-08 | Agronomique Inst Nat Rech | Procede d'obtention de plantes transgeniques, vecteur d'integration utilise et plantes obtenues |
| AU638411B2 (en) * | 1988-02-26 | 1993-07-01 | Large Scale Biology Corporation | Non-nuclear chromosomal transformation |
| CN1033645A (zh) * | 1988-10-22 | 1989-07-05 | 中国科学院上海植物生理研究所 | 控制植物病毒病的基因工程方法 |
-
1990
- 1990-07-27 NL NL9001711A patent/NL9001711A/nl not_active Application Discontinuation
- 1990-10-02 CA CA002396794A patent/CA2396794A1/en not_active Abandoned
- 1990-10-02 CA CA002026703A patent/CA2026703C/en not_active Expired - Fee Related
- 1990-10-03 PT PT95494A patent/PT95494B/pt active IP Right Grant
- 1990-10-03 AT AT90202627T patent/ATE142700T1/de not_active IP Right Cessation
- 1990-10-03 DE DE69028479T patent/DE69028479T2/de not_active Expired - Fee Related
- 1990-10-03 EP EP90202627A patent/EP0425004B1/en not_active Expired - Lifetime
- 1990-10-03 DK DK90202627.7T patent/DK0425004T3/da active
- 1990-10-03 JP JP2266173A patent/JPH03280883A/ja active Pending
- 1990-10-03 ES ES90202627T patent/ES2094744T3/es not_active Expired - Lifetime
- 1990-10-03 IE IE354190A patent/IE76133B1/en not_active IP Right Cessation
-
1996
- 1996-12-10 GR GR960403367T patent/GR3021950T3/el unknown
-
1997
- 1997-07-28 US US08/901,379 patent/US6197542B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE142700T1 (de) | 1996-09-15 |
| JPH03280883A (ja) | 1991-12-11 |
| DK0425004T3 (https=) | 1997-03-10 |
| EP0425004B1 (en) | 1996-09-11 |
| ES2094744T3 (es) | 1997-02-01 |
| GR3021950T3 (en) | 1997-03-31 |
| IE76133B1 (en) | 1997-10-08 |
| US6197542B1 (en) | 2001-03-06 |
| CA2396794A1 (en) | 1991-04-04 |
| DE69028479D1 (de) | 1996-10-17 |
| CA2026703C (en) | 2002-11-26 |
| DE69028479T2 (de) | 1997-04-03 |
| NL9001711A (nl) | 1991-05-01 |
| IE903541A1 (en) | 1991-04-10 |
| PT95494A (pt) | 1991-09-13 |
| EP0425004A3 (en) | 1991-08-07 |
| EP0425004A2 (en) | 1991-05-02 |
| CA2026703A1 (en) | 1991-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT95494B (pt) | Processo para a producao de dna recombinante compreendendo sequencias derivadas de virus de rna, e manipulacoes geneticas que o utilizam | |
| Diener | The viroids | |
| BRPI0707733B1 (pt) | antígeno isolado, composição de vacina, uso da referida composição e método para produção de uma proteína de antígeno | |
| JPS6332488A (ja) | グリホセート耐性キメラ遺伝子 | |
| ES2079647T5 (es) | Transformacion genetica y regeneracion de la remolacha azucarera. | |
| PT97826B (pt) | Processo para a preparacao de purificacao de uma proteina a partir de uma planta com um efeito inibidor num patogenio ou peste e de composicoes anti-fungos que as contem | |
| BRPI9814369B1 (pt) | sequência de dna, gene quimérico, vetor de clonagem, processo de transformação de células vegetais, processo de controle das ervas daninhas e processo de cultura das plantas | |
| Bai et al. | Construction of a fusion anti‐caries DNA vaccine in transgenic tomato plants for PAcA gene and cholera toxin B subunit | |
| AU668387B2 (en) | Process for production of exogenous gene or its product in plant cells | |
| CN116082481A (zh) | 一种影响植物对炭疽病敏感性的转录因子PbbZIP4、蛋白及其应用 | |
| PT81227B (pt) | Celulas vegetais resistentes a inibidores herbicidas de glutamina sintetase | |
| ES2321922T3 (es) | Dna y vector para regular la expresion del gen de la sintasa del factor lacrimatorio, metodo para regular la expresion del gen de la sintasa del factor lacrimatorio mediante su uso, y planta con expresion regulada del gen de la sintasa del factor lacrimatorio. | |
| EP0899340A2 (de) | Virus/Herbizidresistenz-Gene, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| ES2210557T3 (es) | Procedimiento para la induccion de resistencia viral en una planta. | |
| JPH04121200A (ja) | 植物細胞におけるポリペプチドの製造法 | |
| ES2198401T3 (es) | Procedimiento para la produccion de plantas resistentes a agentes patogenos. | |
| US6093554A (en) | Genetics manipulations with recombinant DNA virus comprising sequences derived from RNA virus | |
| KR101428843B1 (ko) | 로타바이러스에 대한 백신효과를 유도하는 형질전환체 및 이를 포함하는 백신 조성물 | |
| CN114507687B (zh) | 水稻OsORM基因及其蛋白的应用 | |
| CN114957417B (zh) | 一种与花粉发育相关的蛋白及其编码基因的应用 | |
| ES2257883T3 (es) | Procedimiento de obtencion de plantas transgenicas que expresan una proteina con actividad productora de peroxido de hidrogeno por transformacion mediante agrobacterium rhizogenes. | |
| TW201713680A (zh) | 嵌合型竹嵌紋病毒蛋白質與粒子、使用嵌合型竹嵌紋病毒載體而從衍生自基因轉殖植物的懸浮細胞中生產它們的方法，以及它們的應用 | |
| Mathews | Strains, field studies, and characterization of the 6.8 K open reading frame of satellite tobacco mosaic virus | |
| CN116004646A (zh) | 一种烟草NtSWEET11基因及其应用 | |
| NL8902452A (nl) | Genetische manipulaties met recombinant dna, dat rna-virus-specifieke sequenties omvat. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19910722 |
|
| FG3A | Patent granted, date of granting |
Effective date: 19970828 |